Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR1302-2 host gene (MIR1302-2HG) is a long non-coding RNA (lncRNA) that is intergenic and classified as a lincRNA_gene; it serves as the host gene for microRNA MIR1302-2, which is itself involved in post-transcriptional regulation of gene expression through miRNA-mediated gene silencing mechanisms. Located on chromosome 1, it does not code for a protein and its functional characterization is limited; there is currently little evidence that it serves as a direct therapeutic target, nor are there established disease associations, interacting drugs, or established biomarker roles[1][4][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR1302-2 host gene (MIR1302-2HG).